Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 126.40
+2.70 (2.18%)
At close: Mar 27, 2026
Akeso Market Cap
Akeso has a market cap or net worth of 116.43 billion as of March 27, 2026. Its market cap has increased by 80.42% in one year.
Market Cap
116.43B
Enterprise Value
111.18B
Revenue
3.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
126.40
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 116.43B, an increase of 527.87%. That is a compound annual growth rate of 36.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 116.43B | 11.86% |
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 245.81B |
| Innovent Biologics | 148.36B |
| WuXi Biologics | 133.89B |
| Sichuan Kelun-Biotech Biopharmaceutical | 106.71B |
| Sino Biopharmaceutical | 105.30B |
| RemeGen | 68.72B |
| 3SBio | 59.89B |
| Biocytogen Pharmaceuticals (Beijing) | 41.27B |